Success Rates and Reporting Guide
Fertility clinic percentages cannot be compared reliably until the outcome, denominator, patient group, treatment type, embryo stage, donor use, and reporting period are understood.
Who this guide is for
Executive summary
Two clinics can publish very different percentages while measuring different outcomes or using different denominators. A pregnancy rate per transfer is not equivalent to a live birth rate per cycle started.
Patient selection also matters. Age, diagnosis, donor use, embryo stage, genetic testing, transfer policy, and case complexity can materially affect a clinic's results.
Success-rate analysis should therefore focus on comparable definitions, appropriate patient groups, transparent exclusions, and clinically meaningful outcomes rather than the largest headline number.
Outcome definitions
Clinics may use several valid outcome measures. The problem arises when the measure is not identified clearly or is presented as though it were directly comparable with a different endpoint.
This generally refers to a pregnancy detected through a positive hormone test. It is an early outcome and does not confirm that a pregnancy is developing normally.
Questions to ask
A clinical pregnancy is usually confirmed by ultrasound evidence, but clinics may differ in the precise definition and timing used.
Questions to ask
This generally refers to a pregnancy continuing beyond a stated gestational point. The threshold can vary and should always be identified.
Questions to ask
Live birth is usually the most meaningful patient-centred endpoint, but interpretation still depends on the denominator, treatment type, age group, and number of embryos transferred.
Questions to ask
Implantation rate usually compares the number of gestational sacs with the number of embryos transferred. It is not the same as the chance of live birth for an individual patient.
Questions to ask
A cumulative rate may include the fresh transfer and later frozen transfers arising from the same retrieval. It can be useful, but only when the time period, included transfers, and patient follow-up are clear.
Questions to ask
Denominator matters
The denominator determines which treatment attempts are counted. Rates based on later stages of treatment often appear higher because earlier unsuccessful or cancelled stages are excluded.
Includes patients from the beginning of treatment, including cycles that do not reach retrieval or transfer. This usually gives a broader picture of the overall treatment pathway.
Excludes cycles cancelled before retrieval. It can appear stronger than a per-cycle-started rate because some unsuccessful cycles are removed from the denominator.
Includes only cases that reached transfer. It does not show the proportion of patients who never produced an embryo suitable for transfer.
May combine more than one treatment attempt for the same person. The timeframe and number of included cycles must be understood.
Comparison context
Age can materially affect outcomes when a patient's own eggs are used. Broad clinic-wide averages may be misleading if age groups are not separated.
Donor-egg outcomes often reflect donor age more than recipient age. Combining donor and non-donor treatment can distort comparisons.
Fresh and frozen embryo transfers involve different clinical circumstances. Combined reporting can hide meaningful differences.
Cleavage-stage and blastocyst transfers are not directly equivalent. Clinics may also differ in which patients reach blastocyst transfer.
Results involving tested embryos should not be compared directly with untested embryo transfers without understanding patient selection and reporting methods.
Transferring more embryos may increase pregnancy rates while also increasing multiple-pregnancy risk. A higher rate is not automatically a safer or better result.
Clinics treating more complex patients may report lower headline outcomes despite strong clinical capability. Patient mix matters.
Clinics differ in when they cancel cycles or decline transfer. Aggressive selection can improve published rates while excluding more difficult cases.
Practical process
Determine whether the clinic is reporting biochemical pregnancy, clinical pregnancy, ongoing pregnancy, live birth, implantation, or cumulative live birth.
Confirm whether the number is calculated per cycle started, retrieval, transfer, or patient.
Compare results only when age, diagnosis, egg source, embryo stage, treatment type, and testing status are reasonably aligned.
Ask which patients or cycles are excluded and how cancelled cycles, no-transfer cycles, and lost follow-up are handled.
Review multiple-birth rates, transfer practices, adverse outcomes, and whether the clinic explains limitations without relying on marketing claims.
Comparison matrix
Before comparing two percentages, confirm that every row in the matrix is reasonably aligned. A mismatch in any major category can make the comparison unreliable.
Red flags
A clinic guarantees pregnancy or live birth.
A success rate is presented without naming the outcome being measured.
The denominator is missing or unclear.
Donor-egg and own-egg results are combined without explanation.
Age groups are absent or unusually broad.
Fresh, frozen, tested, and untested embryo transfers are blended together.
Cancellation and no-transfer cycles are not disclosed.
The clinic highlights pregnancy rates but does not provide live birth data where available.
Multiple-birth rates or embryo-transfer practices are omitted.
The clinic refuses to explain how its figures were calculated.
Clinic-question checklist
Ask for written definitions and context. Transparent clinics should be able to explain how their published figures were calculated and what their limitations are.
Related resources
Use a structured framework to evaluate clinic suitability.
Assess country fit before comparing individual providers.
Explore jurisdiction dossiers and regulatory context.
Review available country-to-country comparisons.
Browse FertilityCareHub planning resources.
Review structured advisory pathways.
Frequently asked questions
For many patients, live birth rate is more meaningful than pregnancy rate because it measures a later outcome. However, it still must be interpreted with the correct denominator, patient group, treatment type, and embryo-transfer context.
A per-transfer rate excludes cycles that did not reach embryo transfer. A per-cycle-started rate includes more of the treatment pathway, including cancellations and cycles that produced no transferable embryo.
Not directly. Donor-egg outcomes often reflect the donor's age and selection criteria, while own-egg outcomes are strongly influenced by the patient's age and individual clinical circumstances.
Not necessarily. Patient selection, transfer practices, number of embryos transferred, reporting definitions, case complexity, and exclusion rules can all affect the published percentage.
They can provide general context, but their usefulness depends on the quality of the underlying data and whether the inputs reflect the patient's circumstances. They should not replace individualized clinical advice.
No. FertilityCareHub uses structured evaluation principles and does not treat a single published rate as proof of clinic quality or patient suitability.
Private strategic advisory
FertilityCareHub helps structure clinic evaluation around comparable definitions, patient context, jurisdiction fit, treatment needs, costs, documentation, and execution risk.
Request a strategy reviewLast reviewed: July 15, 2026. This guide explains common fertility outcome measures and reporting limitations. It does not independently validate any clinic's published results or rank providers.
FertilityCareHub does not provide medical diagnosis, treatment, or guaranteed outcomes. A clinic's statistics cannot predict an individual result. Discuss personal prognosis and treatment decisions with a licensed fertility specialist.
Read the full disclaimer